Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00915551 · ClinicalTrials.gov registry record · Phase 3
A Multi-Center Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on the Head (Face or Scalp)
A Phase 3 study, sponsored by Peplin.
- Completed
- Registry status
- Phase 3
- Development phase
- 278
- Enrollment target
NCT00915551 is a Phase 3 study that has completed, run by Peplin. The registered enrollment target is 278 participants.
The verdict
NCT00915551, a Phase 3 study, has completed, sponsored by Peplin.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 278 participants
- Enrollment target
Study Summary
This Phase III study is designed to assess the efficacy and safety of PEP005 Gel, 0.015% when applied to an area of skin containing 4-8 AK lesions on the face or scalp.
Interventions
- DRUG Vehicle Gel
- DRUG PEP005 (Ingenol Mebutate) gel, 0.015%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 278 participants |
| Start Date | 2009-06 |
| Est. Completion | 2009-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00915551
The ClinicalTrials.gov registry entry for NCT00915551 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 278 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Peplin, which has 19 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vehicle Gel is the first listed.
NCT00915551 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00915551 about?
NCT00915551 is a clinical study titled "A Multi-Center Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on the Head (Face or Scalp)". This Phase III study is designed to assess the efficacy and safety of PEP005 Gel, 0.015% when applied to an area of skin containing 4-8 AK lesions on the face or scalp.
What is the current status of trial NCT00915551?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 278 participants. The study started on 2009-06. Estimated completion is 2009-09.
What interventions are being tested in trial NCT00915551?
The interventions under investigation include: Vehicle Gel (DRUG), PEP005 (Ingenol Mebutate) gel, 0.015% (DRUG).
Who is sponsoring clinical trial NCT00915551?
This trial is sponsored by Peplin, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.